ID
33521
Description
Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria
Keywords
Versions (4)
- 12/11/18 12/11/18 -
- 6/6/19 6/6/19 -
- 6/12/19 6/12/19 -
- 9/27/21 9/27/21 -
Copyright Holder
GSK group of companies
Uploaded on
December 11, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Immunogenicity of malaria vaccine candidate in Mozambican children (1 to 4 y.o) - 104297 (Malaria039)
Visit 2: Laboratory Tests - Serology
- StudyEvent: ODM
Description
Blood Sample for Antibodies to CS
Description
Blood Sample for Antibodies to HBs
Description
Blood Sample for Hematocrit
Description
Test
Description
PCV (Packed cell volume) / Hematocrit
Data type
text
Description
Results
Data type
float
Measurement units
- %
Description
Out of range values
Data type
integer
Description
If Other, please specify
Data type
text
Similar models
Visit 2: Laboratory Tests - Serology
- StudyEvent: ODM
No comments